![Barbara Schaeffler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Schaeffler is Senior VP-Clinical Development Operations at Zymeworks, Inc. starting in 2025.
Formerly, Ms. Schaeffler was Vice President-Clinical Operations at Syndax Pharmaceuticals, Inc. from 2022 to 2023.
Education includes undergraduate and MBA degrees from the University of California.
| Sociétés | Poste | Début |
|---|---|---|
| ZYMEWORKS INC. | Directeur Technique/Scientifique/R&D | 01/01/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2023 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
